This study explores the role of interleukin‐17 (IL‐17) in driving gut pain in gastrointestinal disease, highlighting how the IL‐23/IL‐17 signalling pathway, known for its role in mucosal inflammation, also contributes to neuronal sensitisation. This evidence concerns the gene IL17A and gastrointestinal disease.